Clinical Trial Update: Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90° [NA]

View source ↗

Summary

This is a completed clinical trial evaluating the probiotic VSL#3 in pediatric obesity, examining metabolic, endocrine, lipidomic, and inflammatory parameters. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• VSL#3

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Obesity | NA | Status: COMPLETED